Target upgraded, CVS downgraded: Wall Street's top analyst calls [Yahoo! Finance]
Insulet Corporation (PODD)
Last insulet corporation earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insulet.com/investor-relations
Company Research
Source: Yahoo! Finance
Top 5 Upgrades: Citi upgraded Target (TGT) to Buy from Neutral with an unchanged price target of $180. The firm believes Target has emerged as "one of the winners within the retail landscape" with an opportunity to improve EBIT margin in the years to come. Citi upgraded Gap (GPS) to Buy from Neutral with a price target of $28, up from $21. After a strong Q4 where both Old Navy and Gap showed momentum and margins significantly above expectations, management guided fiscal 2024 earnings "very conservatively," the firm tells investors in a research note. Wolfe Research upgraded Insulet (PODD) to Outperform from Peer Perform with a $200 price target. The firm cites the company's growing type 1 diabetes share gains, outside the U.S. catalysts, profitability potentially a "coiling spring," and a "less demanding" share valuation for the upgrade. Barclays upgraded Omnicom (OMC) to Overweight from Equal Weight with a price target of $110, up from $100. The firm says Omnicom shares are
Show less
Read more
Impact Snapshot
Event Time:
PODD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PODD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PODD alerts
High impacting Insulet Corporation news events
Weekly update
A roundup of the hottest topics
PODD
News
- Will Insulet's Monopoly Crumble? Appellate Court Ruling Signals Shift in Automated Insulin Delivery Systems Market [Yahoo! Finance]Yahoo! Finance
- Insulet (PODD) Q1 Earnings Top, 2024 Revenue View Raised [Yahoo! Finance]Yahoo! Finance
- Results: Insulet Corporation Beat Earnings Expectations And Analysts Now Have New Forecasts [Yahoo! Finance]Yahoo! Finance
- Insulet Corporation (NASDAQ:PODD) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at Canaccord Genuity Group Inc. from $226.00 to $234.00. They now have a "buy" rating on the stock.MarketBeat
PODD
Earnings
- 5/9/24 - Beat
PODD
Sec Filings
- 5/10/24 - Form 10-Q
- 5/9/24 - Form 8-K
- 5/2/24 - Form 4
- PODD's page on the SEC website